{"nct_id":"NCT07186101","title":"LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:","status":"NOT_YET_RECRUITING","status_verified_date":"2025-10","start_date":"2025-11","start_date_type":"ESTIMATED","primary_completion_date":"2027-05","primary_completion_date_type":"ESTIMATED","completion_date":"2029-03","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["LLY"]}